文献速递心外重症与机械循环支持

RecoverHeart计算器:预测左心室辅助装置支持后心肌恢复的个体化概率

Determining the individualized probability of myocardial recovery: The multicenter RecoverHeart calculator.
PubMed 文献 · J Heart Lung Transplant · 2026-04-17

研究基于5家机构509例连续流LVAD慢性心衰患者建立并外部验证(4家机构375例)RecoverHeart计算器,用于预测LVAD植入1年内显著逆重构(LVEF≥40%且LVEDD≤6 cm)的个体化概率。推导队列发生率14.9%、验证队列11.2%,C统计量分别为0.72和0.75,模型区分度良好且优于既往模型。

要点

  • RecoverHeart计算器可个体化预测LVAD支持后1年内显著逆重构的概率。
  • 女性、心衰病程短、非缺血性心肌病及左室舒张末径较小是主要术前预测因素。
  • 模型区分度良好(推导队列C统计量0.72,验证队列0.75),有助于共享决策。

核心结论

  • RecoverHeart计算器是实用且经过验证的工具,可估算LVAD患者发生显著逆重构的个体化概率。
  • 该工具通过辅助患者选择和咨询,可能促进共享决策并改善LVAD作为桥接恢复策略的使用不足。

研究设计与样本

  • 推导队列纳入5家机构的509例连续流LVAD慢性心衰患者,外部验证队列纳入4家机构的375例患者。
  • 主要模型终点为LVAD植入1年内达到显著逆重构,即LVEF≥40%且左室舒张末径≤6 cm。
  • 建立多变量预测模型并外部验证,形成RecoverHeart计算器。

主要发现

  • 推导队列中76例(14.9%)出现显著逆重构,验证队列中42例(11.2%)出现显著逆重构。
  • 关键术前预测因素包括女性、心衰病程较短、非缺血性心肌病和较小的左室舒张末径。
  • 模型区分度良好,推导队列C统计量0.72(95%CI:0.66-0.79),验证队列0.75(95%CI:0.67-0.84)。
  • 模型预测概率覆盖0.2%-67.6%的广泛范围,且优于既往发表的模型和单个预测因素。

关键数值与推荐

  • 显著逆重构定义为LVAD植入1年内LVEF≥40%且左室舒张末径≤6 cm。
  • 推导队列显著逆重构发生率14.9%(76/509),验证队列11.2%(42/375)。
  • 推导队列C统计量0.72(95%CI:0.66-0.79),验证队列0.75(95%CI:0.67-0.84)。
  • 模型预测概率范围为0.2%-67.6%。

临床怎么用

  • 可用于LVAD植入前咨询,帮助心衰患者和临床医生了解个体化心肌恢复概率。
  • 有助于识别可能从桥接恢复策略中获益的患者,优化LVAD与心脏移植的治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent reports from UNOS and INTERMACS highlight that left ventricular assist devices (LVADs) remain underutilized as a bridge-to-recovery (BTR) strategy, despite data from registries and other studies demonstrating that a meaningful subset of patients experience substantial improvements in cardiac structure and function during LVAD support. A reliable tool to estimate the likelihood of cardiac recovery could aid clinicians and heart failure (HF) patients in making informed decisions when considering advanced therapies such as LVAD implantation and heart transplantation. OBJECTIVES: To develop and externally validate a practical calculator estimating an individual patient's likelihood of cardiac recovery during LVAD support. METHODS: The derivation cohort included chronic HF patients supported with continuous-flow LVADs from 5 institutions. An external validation cohort comprised patients from 4 additional institutions. The primary model endpoint was "significant reverse remodeling," defined as achieving LVEF ≥40% and LV end-diastolic diameter ≤6 cm within 1 year of LVAD implantation. A multivariable prediction model estimating the individualized probability of this outcome was developed and externally validated as the RecoverHeart calculator. RESULTS: The derivation cohort included 509 patients, and the validation cohort comprised 375 patients. Significant reverse remodeling was observed in 76 patients (14.9%) in the derivation cohort and 42 patients (11.2%) in the validation cohort. Key preimplant predictors included female sex, shorter HF duration, non-ischemic cardiomyopathy, and smaller left ventricular end-diastolic diameter. The RecoverHeart calculator demonstrated good discrimination, with a C statistic of 0.72 (95% CI: 0.66-0.79) in the derivation cohort and 0.75 (95% CI: 0.67-0.84) in the validation cohort. The model stratified patients across a wide range of predicted probabilities for significant reverse remodeling (0.2%-67.6%) and outperformed previously published models and individual predictors. CONCLUSIONS: The RecoverHeart calculator is a practical and validated tool that estimates the individualized probability of significant reverse remodeling in LVAD patients. By informing patient selection and counseling, it may facilitate shared decision-making, help address the underutilization of LVADs as BTR therapy, and maximize the therapeutic benefits of both LVAD and heart transplantation.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Taleb I, Kyriakopoulos CP, Wever-Pinzon O, et al. Determining the individualized probability of myocardial recovery: The multicenter RecoverHeart calculator. J Heart Lung Transplant. 2026. PMID: 42001916. doi:10.1016/j.healun.2026.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。